Financials The Clorox Company

Equities

CLX

US1890541097

Household Products

Market Closed - Nyse 04:00:02 2024-04-26 pm EDT 5-day change 1st Jan Change
146.5 USD -0.69% Intraday chart for The Clorox Company +2.04% +2.73%

Valuation

Fiscal Period: Juni 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 19,501 27,626 22,376 17,352 19,661 18,179 - -
Enterprise Value (EV) 1 22,073 29,535 24,841 19,880 21,821 20,538 20,471 20,360
P/E ratio 24.2 x 29.8 x 32.2 x 37.8 x 133 x 49.5 x 25.5 x 23.2 x
Yield 2.57% 1.93% 2.5% 3.31% - 3.29% 3.44% 3.56%
Capitalization / Revenue 3.14 x 4.11 x 3.05 x 2.44 x 2.66 x 2.52 x 2.43 x 2.36 x
EV / Revenue 3.55 x 4.39 x 3.38 x 2.8 x 2.95 x 2.84 x 2.73 x 2.64 x
EV / EBITDA 16.9 x 20.3 x 16.9 x 20.4 x 18.9 x 16.7 x 14.9 x 13.9 x
EV / FCF 28.1 x 22.9 x 26.3 x 37.2 x 23.5 x 42.8 x 25.2 x 22.8 x
FCF Yield 3.56% 4.37% 3.8% 2.69% 4.26% 2.34% 3.97% 4.39%
Price to Book 35 x 28.2 x 53.9 x 31.2 x - 150 x 49.6 x 28.2 x
Nbr of stocks (in thousands) 127,368 125,934 124,372 123,080 123,624 124,106 - -
Reference price 2 153.1 219.4 179.9 141.0 159.0 146.5 146.5 146.5
Announcement Date 8/1/19 8/3/20 8/3/21 8/3/22 8/2/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Juni 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 6,214 6,721 7,341 7,107 7,389 7,227 7,486 7,713
EBITDA 1 1,304 1,454 1,467 974 1,153 1,227 1,378 1,469
EBIT 1 1,124 1,274 1,256 750 917 1,006 1,154 1,233
Operating Margin 18.09% 18.96% 17.11% 10.55% 12.41% 13.92% 15.42% 15.98%
Earnings before Tax (EBT) 1 1,024 1,185 900 607 238 493.3 979.9 1,063
Net income 1 820 939 710 462 149 370.2 714.5 785
Net margin 13.2% 13.97% 9.67% 6.5% 2.02% 5.12% 9.54% 10.18%
EPS 2 6.320 7.360 5.580 3.730 1.200 2.962 5.743 6.319
Free Cash Flow 1 786 1,292 945 535 930 479.8 811.9 893.8
FCF margin 12.65% 19.22% 12.87% 7.53% 12.59% 6.64% 10.85% 11.59%
FCF Conversion (EBITDA) 60.28% 88.86% 64.42% 54.93% 80.66% 39.12% 58.91% 60.83%
FCF Conversion (Net income) 95.85% 137.59% 133.1% 115.8% 624.16% 129.61% 113.63% 113.85%
Dividend per Share 2 3.940 4.240 4.490 4.660 - 4.815 5.033 5.220
Announcement Date 8/1/19 8/3/20 8/3/21 8/3/22 8/2/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3
Net sales 1 1,806 1,691 1,809 1,801 1,740 1,715 1,915 2,019 1,386 1,990 1,871 1,982 1,733 1,795 1,890
EBITDA 1 274 185 304 240 228 233 357 356 152 443 301.1 333.6 314.3 337.7 341.6
EBIT 1 231 130 247 183 172 175 297 294 91 386 247.3 279 237.7 296.3 282.1
Operating Margin 12.79% 7.69% 13.65% 10.16% 9.89% 10.2% 15.51% 14.56% 6.57% 19.4% 13.22% 14.08% 13.72% 16.5% 14.93%
Earnings before Tax (EBT) 1 185 93 200 129 116 130 -245 237 29 136 -13.53 218.5 206.8 239.7 238.7
Net income 1 142 69 150 101 85 99 -211 176 22 93 77.56 175.1 159.4 187.3 182.6
Net margin 7.86% 4.08% 8.29% 5.61% 4.89% 5.77% -11.02% 8.72% 1.59% 4.67% 4.15% 8.84% 9.2% 10.44% 9.66%
EPS 2 1.140 0.5600 1.210 0.8100 0.6800 0.8000 -1.710 1.420 0.1700 0.7500 0.4484 1.387 1.315 1.482 1.453
Dividend per Share 2 1.160 1.160 1.160 1.180 2.360 1.180 1.180 - 2.400 - 1.206 1.231 1.249 1.249 1.266
Announcement Date 11/1/21 2/3/22 5/2/22 8/3/22 11/1/22 2/2/23 5/2/23 8/2/23 11/1/23 2/1/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 2,572 1,909 2,465 2,528 2,160 2,359 2,291 2,181
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.972 x 1.313 x 1.68 x 2.595 x 1.873 x 1.924 x 1.663 x 1.485 x
Free Cash Flow 1 786 1,292 945 535 930 480 812 894
ROE (net income / shareholders' equity) 128% 128% 108% 95.6% 19.2% 310% 280% 180%
ROA (Net income/ Total Assets) 16.1% 16.6% 11.3% 7.4% 2.46% 5.84% 12.5% 14.3%
Assets 1 5,088 5,665 6,273 6,246 6,052 6,339 5,715 5,500
Book Value Per Share 2 4.380 7.770 3.340 4.510 - 0.9800 2.950 5.190
Cash Flow per Share 2 7.640 12.10 10.10 6.340 9.330 4.140 7.770 8.710
Capex 1 206 254 331 251 228 205 239 246
Capex / Sales 3.32% 3.78% 4.51% 3.53% 3.09% 2.84% 3.19% 3.19%
Announcement Date 8/1/19 8/3/20 8/3/21 8/3/22 8/2/23 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
21
Last Close Price
146.5 USD
Average target price
154.1 USD
Spread / Average Target
+5.17%
Consensus
  1. Stock Market
  2. Equities
  3. CLX Stock
  4. Financials The Clorox Company